Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-25 @ 2:09 AM
NCT ID:
NCT07054060
Eligibility Criteria:
Inclusion Criteria:
* Patient age 18 years or over
* Hemispheric or retinal transient ischemic attack or a non-disabling stroke (or retinal infarct) within 15 days before enrolment
* Stenosis of 50% to 99% in the symptomatic carotid artery (NASCET method) for whom revascularisation is decided according to guidelines
Exclusion Criteria:
* Patients unwilling or unable to participate in follow-up for whatever reason
* Preexisting disability (Modified Rankin Score ≥ 3)
* Nonatherosclerotic carotid disease
* Severe tandem lesions
* Previous revascularization of the symptomatic carotid stenosis
* History of bleeding disorder
* Unstable angina
* Contraindication to dual antiplatelet therapy
* Contraindication to MRI
* Life expectancy of less than 2 years
* Percutaneaous or surgical intervention within 30 days before or after the study procedure
* Stenotic lesion on arterial workup appeared as not a factor in the selection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07054060
Study Brief:
Protocol Section:
NCT07054060